LACK OF INTERACTION BETWEEN VERAPAMIL AND CIMETIDINE

被引：20
作者：
ABERNETHY, DR
SCHWARTZ, JB
TODD, EL
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 38卷 / 03期
关键词：
D O I：
10.1038/clpt.1985.183
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：342 / 349
页数：8
相关论文
共 32 条
[1]  
ABERNETHY DR, 1983, J PHARMACOL EXP THER, V224, P508
[2]   VERAPAMIL AND NORVERAPAMIL DETERMINATION IN HUMAN-PLASMA BY GAS-LIQUID-CHROMATOGRAPHY USING NITROGEN-PHOSPHORUS DETECTION - APPLICATION TO SINGLE-DOSE PHARMACOKINETIC STUDIES [J].
ABERNETHY, DR ;
TODD, EL ;
MITCHELL, JR .
PHARMACOLOGY, 1984, 29 (05) :264-268
[3]   LIDOCAINE DETERMINATION IN HUMAN-PLASMA WITH APPLICATION TO SINGLE LOW-DOSE PHARMACOKINETIC STUDIES [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
OCHS, HR .
JOURNAL OF CHROMATOGRAPHY, 1982, 232 (01) :180-185
[4]  
ABERNETHY DR, 1984, J PHARMACOL EXP THER, V229, P702
[5]   CIMETIDINE-INDUCED DECREASE IN LIDOCAINE METABOLISM [J].
BAUER, LA ;
EDWARDS, WAD ;
RANDOLPH, FP ;
BLOUIN, RA .
AMERICAN HEART JOURNAL, 1984, 108 (02) :413-415
[6]  
EICHELBAUM M, 1979, DRUG METAB DISPOS, V7, P145
[7]   EFFECTS OF VERAPAMIL ON P-R-INTERVALS IN RELATION TO VERAPAMIL PLASMA-LEVELS FOLLOWING SINGLE IV AND ORAL-ADMINISTRATION AND DURING CHRONIC TREATMENT [J].
EICHELBAUM, M ;
BIRKEL, P ;
GRUBE, E ;
GUTGEMANN, U ;
SOMOGYI, A .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (18) :919-925
[8]   INCREASED TOXICITY AND REDUCED CLEARANCE OF LIDOCAINE BY CIMETIDINE [J].
FEELY, J ;
WILKINSON, GR ;
MCALLISTER, CB ;
WOOD, AJJ .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) :592-594
[9]   REDUCTION OF LIVER BLOOD-FLOW AND PROPRANOLOL METABOLISM BY CIMETIDINE [J].
FEELY, J ;
WILKINSON, GR ;
WOOD, AJJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12) :692-695
[10]   CLINICAL PHARMACOKINETICS OF VERAPAMIL [J].
HAMANN, SR ;
BLOUIN, RA ;
MCALLISTER, RG .
CLINICAL PHARMACOKINETICS, 1984, 9 (01) :26-41
1234